Stroke Disorder & Treatment Market 2021, Industry Size, Share, Growth, SWOT Analysis, Demand Overview, Top Company Profile, Key Regions, Forecast to 2022
Research Reports
Dec 28, 2020
Stroke disorders are an array of disorders caused by strokes. High stress levels, alcoholism, and other factors are accountable for maximum number of stroke cases. The global stroke & disorder treatment report by Market Research Future (MRFR) contains drivers and challenges to be faced by industry leaders for the period of 2016 to 2022 (forecast period). It also takes into consideration the impact of COVID-19 on market dynamics.
Stroke Disorder & Treatment Market Outlook
The global stroke disorder treatment market is predicted to scale during the forecast period owing to the rise in the number of cases of cardiovascular diseases, diabetes, and others. Rising prevalence of chronic disorders can fuel the market demand. The large geriatric populace susceptible to strokes owing to their age and weak immune system can create demand in the market.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/1651
Awareness of strokes is expected to augur favorably for the market. Public awareness campaigns endorsed by celebrities and recognizable celebrities can lead to huge amount of testing. Initiatives to train doctors for improving the outcomes of heart surgeries are expected to drive the market growth. The introduction of mobile stroke units in hospitals is a positive step in the market. Furthermore, the COVID-19 pandemic is showing strokes in patients between the ages of 30 and 40 furthering the market prospects.
But high costs of treatment and lengthy process for approval of devices and equipment can hamper market growth.
Stroke Disorder & Treatment Market Segmentation
The global stroke disorder & treatment market has been segmented by type, medicine, and treatment.
By type, it is divided into ischemic stroke and hemorrhagic stroke. Ischemic strokes are expected to lead in the global market due to rise in these cases.
Medicines produced in the market are of 2 types, anticoagulants/antiplatelet and anti-hypertensive. Anticoagulants are blood thinners which prevent the thickness of blood which can cause clots. Some drugs able to prevent strokes include warfarin, Apixaban, edoxaban, dabigatran, rivaroxaban, heparin, and enoxaparin. Antihypertensives are a drug class able to treat high blood pressure.
By treatment, the market includes endovascular procedures, carotid endarterectomy, tissue plasminogen activator (TPA), surgical treatment, and others. The endovascular procedures segment is projected to perform exceptionally during the forecast period owing to being minimally invasive in nature. It is used in the treatment of aneurysms.
Stroke Disorder & Treatment Market Regional Analysis
Europe, North America, Asia Pacific (APAC), and Rest-of-the-World (RoW) are regions covered in the global stroke disorder treatment market.
North America is expected to register high revenue for the global market due to the large number of cases of strokes and investments in advanced medical facilities. According to the American Medical Association, the geriatric pool of patients in the U.S. is susceptible to strokes. Presence of prominent names and launch of continuous products can fuel the market growth to new heights.
Europe is projected to show maximum growth owing to inclination towards minimally invasive treatments and encouragement of new techniques. The use of artificial intelligence to improve the outcomes of surgeries is a positive step in stroke treatment.
APAC is expected to display a stellar growth rate owing to establishment of facilities to handle strokes. Adoption of portable devices to resuscitate patients in ambulances as well as hiring of skilled specialists can drive the regional market. Improvements in healthcare infrastructure as well as the continuous growth of developing economies can bode well for the market.
Stroke Disorder & Treatment Market Competition Outlook
Pfizer, Novartis AG, Daiichi Sankyo, AstraZeneca, Bayer Pharma AG, and others are key players of the global stroke disorder treatment market.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/stroke-disorder-treatment-market-1651
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English